يعرض 1 - 10 نتائج من 374 نتيجة بحث عن '"R. Ramazanov"', وقت الاستعلام: 0.86s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية

    المساهمون: The study has no sponsorship, Исследование не имеет спонсорской поддержки

    المصدر: Russian Sklifosovsky Journal "Emergency Medical Care"; Том 12, № 4 (2023); 683-689 ; Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь»; Том 12, № 4 (2023); 683-689 ; 2541-8017 ; 2223-9022

    وصف الملف: application/pdf

    العلاقة: https://www.jnmp.ru/jour/article/view/1733/1367Test; Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15(4):391–404. PMID: 26906964 doi:10.1016/S1474-4422(15)00401-9; Flanagan EP, Geschwind MD, Lopez-Chiriboga AS, Blackburn KM, Turaga S, Binks S, et al. Autoimmune Encephalitis Misdiagnosis in Adults. JAMA Neurol. 2023;80(1):30–39. PMID: 36441519 doi:10.1001/jamaneurol.2022.4251; Kotsenas AL, Watson RE, Pittock SJ, Britton JW, Hoye SL, Quek AM, et al. MRI findings in autoimmune voltage-gated potassium channel complex encephalitis with seizures: one potential etiology for mesial temporal sclerosis. AJNR Am J Neuroradiol. 2014;35(1):84–89. PMID: 23868165 doi:10.3174/ajnr.A3633; Balu R, McCracken L, Lancaster E, Graus F, Dalmau J, Titulaer MJ. A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis. Neurology. 2019;92(3):e244–e252. PMID: 30578370 doi:10.1212/WNL.0000000000006783; Gultekin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JB, Dalmau J. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain. 2000;123(Pt 7):1481–1494. PMID: 10869059 doi:10.1093/brain/123.7.1481; Titulaer MJ, McCracken L, Gabilondo I, Armangué T, Glaser C, Iizuka T, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013;12(2):157–165. PMID: 23290630 doi:10.1016/S1474-4422(12)70310-1; da Rocha AJ, Nunes RH, Maia AC Jr, do Amaral LL. Recognizing Autoimmune-Mediated Encephalitis in the Differential Diagnosis of Limbic Disorders. AJNR Am J Neuroradiol. 2015;36(12):2196–2205. PMID: 26381566 doi:10.3174/ajnr.A4408; Abboud H, Probasco J, Irani SR, Ances B, Benavides DR, Bradshaw M, et al.; Autoimmune Encephalitis Alliance Clinicians Network. Autoimmune encephalitis: proposed recommendations for symptomatic and long-term management. J Neurol Neurosurg Psychiatry. 2021;92(8):897–907. PMID: 33649021 doi:10.1136/jnnp-2020-325302; Shahrizaila N, Yuki N. Bickerstaff brainstem encephalitis and Fisher syndrome: anti-GQ1b antibody syndrome. J Neurol Neurosurg Psychiatry. 2013;84(5):576–583. PMID: 22984203 doi:10.1136/jnnp-2012-302824; Zhou JY, Xu B, Lopes J, Blamoun J, Li L. Hashimoto encephalopathy: literature review. Acta Neurol Scand. 2017;135(3):285–290. PMID: 27324276 doi:10.1111/ane.12618; Lu J, Zhang JH, Miao AL, Yin JX, Zhu DL, Lin XJ, et al. Brain astrocytoma misdiagnosed as anti-NMDAR encephalitis: a case report. BMC Neurol. 2019;19(1):210. PMID: 31462223 doi:10.1186/s12883-019-1436-x; Sechi E, Flanagan EP. Antibody-Mediated Autoimmune Diseases of the CNS: Challenges and Approaches to Diagnosis and Management. Front Neurol. 2021;12:673339. PMID: 34305787 doi:10.3389/fneur.2021.673339; Zuliani L, Graus F, Giometto B, Bien C, Vincent A. Central nervous system neuronal surface antibody associated syndromes : review and guidelines for recognition. J Neurol Neurosurg Psychiatry. 2012;83(6):638–645. PMID: 22448032 doi:10.1136/jnnp-2011-301237; Nabizadeh F, Balabandian M, Sodeifian F, Rezaei N, Rostami MR, Naser Moghadasi A. Autoimmune encephalitis associated with COVID-19 : A systematic review. Mult Scler Relat Disord. 2022;62:103795. PMID: 35472834 doi:10.1016/j.msard.2022.103795; Pearce JM. Paraneoplastic limbic encephalitis. Eur Neurol. 2005;53(2):106–108. PMID: 15855786 doi:10.1159/000085512; https://www.jnmp.ru/jour/article/view/1733Test

  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية

    المصدر: Russian Sklifosovsky Journal "Emergency Medical Care"; Том 11, № 4 (2022); 561-572 ; Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь»; Том 11, № 4 (2022); 561-572 ; 2541-8017 ; 2223-9022

    وصف الملف: application/pdf

    العلاقة: https://www.jnmp.ru/jour/article/view/1513/1232Test; Chen Y, Wright N, Guo Y, Turnbull I, Kartsonaki C, Yang L, et al. Mortality and recurrent vascular events after first incident stroke: a 9year community-based study of 0·5 million Chinese adults. Lancet Glob Health. 2020;8(4):e580–e590. PMID: 32199124 https://doi.org/10.1016/S2214-109XTest(20)30069-3; GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1151–1210. PMID: 28919116 https://doi.org/10.1016/S0140-6736Test(17)32152-9; Xing C, Arai K, Lo EH, Hommel M. Pathophysiologic cascades in ischemic stroke. Int J Stroke. 2012;7(5):378–385. PMID: 22712739 https://doi.org/10.1111/j.1747-4949.2012.00839.xTest; Шамалов Н.А., Стаховская Л.В., Клочихина О.А., Полунина О.С., Полунина Е.А. Анализ динамики основных типов инсульта и патогенетических вариантов ишемического инсульта. Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски. 2019;119(3–2):5– 10. https://doi.org/10.17116/jnevro20191190325Test; Donkor ES. Stroke in the 21st Century: A Snapshot of the Burden, Epidemiology, and Quality of Life. Stroke Res Treat. 2018;2018:3238165. PMID: 30598741 https://doi.org/10.1155/2018/3238165Test; Paul S, Candelario-Jalil E. Emerging neuroprotective strategies for the treatment of ischemic stroke: An overview of clinical and preclinical studies. Exp Neurol. 2021;335:113518. PMID: 33144066 https://doi.org/10.1016/j.expneurol.2020.113518Test; Острова И.В., Гребенчиков О.А., Голубева Н.В. Нейропротективное действие хлорида лития на модели остановки сердца у крыс. Общая реаниматология. 2019;15(3):73–82. https://doi.org/10.15360/18139779-2019-3-73-82Test; Chamorro Á, Meisel A, Planas AM, Urra X, van de Beek D, Veltkamp R. The immunology of acute stroke. Nat Rev Neurol. 2012;8(7):401–410. PMID: 22664787 https://doi.org/10.1038/nrneurol.2012.98Test; Veltkamp R, Gill D. Clinical Trials of Immunomodulation in Ischemic Stroke. Neurotherapeutics. 2016;13(4):791–800. PMID: 27412685 https://doi.org/10.1007/s13311-016-0458-yTest; Wilhelm S, Ma D, Maze M, Franks NP. Effects of xenon on in vitro and in vivo models of neuronal injury. Anesthesiology. 2002;96(6):1485–1491. PMID: 12170064 https://doi.org/10.1097/00000542-200206000-00031Test; David HN, Leveille F, Chazalviel L, MacKenzie ET, Buisson A, Lemaire M, et al. Reduction of ischemic brain damage by nitrous oxide and xenon. J Cereb Blood Flow Metab. 2003;23(10):1168-1173. PMID: 14526227 https://doi.org/10.1097/01.WCB.0000087342.31689.18Test; Alam A, Suen KC, Hana Z, Sanders RD, Maze M, Ma D. Neuroprotection and neurotoxicity in the developing brain: an update on the effects of dexmedetomidine and xenon. Neurotoxicol Teratol. 2017;60:102–116. PMID: 28065636 https://doi.org/10.1016/j.ntt.2017.01.001Test; Laitio R, Hynninen M, Arola O, Virtanen S, Parkkola R, Saunavaara J, et al. Effect of Inhaled Xenon on Cerebral White matter Damage in Comatose Survivors of Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial. JAMA. 2016;315(11):1120–1128. PMID: 26978207 https://doi.org/10.1001/jama.2016.1933Test; Maze M, Laitio T. Xenon limits brain damage following cardiac arrest. ICU Management & Practice. 2018;18(special suppl. 3 Shock):192–195.; Гребенчиков О.А., Шабанов А.К., Николаев Л.Л., Шпичко А.И., Братищев И.В., Марченко Л.Ю., и др. Влияние ксенона на провоспалительную активацию и апоптоз нейтрофилов человека в условиях ex vivo. Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь». 2021;10(3):511–520. https://doi.org/10.23934/2223-90222021-10-3-511-520Test; Кузовлев А.Н., Шпичко А.И., Рыжков И.А., Гребенчиков О.А., Шабанов А.К., Хусаинов Ш.Ж., и др. Влияние ксенона на фосфорилирование киназы гликогенсинтазы-3ẞ и антиоксидантные ферменты в мозге крыс. Журнал им. Н.В. Склифосовского Неотложная медицинская помощь. 2020;9(4):564–572. https://doi.org/10.23934/2223-90222020-9-4-564-57213Test; Filev AD, Silachev DN, Ryzhkov IA, Lapin KN, Babkina AS, Grebenchikov OA, et al. Effect of Xenon Treatment on Gene Expression in Brain Tissue after Traumatic Brain Injury in Rats. Brain Sci. 2021;11(7):889. PMID: 34356124 https://doi.org/10.3390/brainsci11070889Test; Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974;2(7872):81–84. PMID: 4136544 https:// doi.org/10.1016/s0140-6736(74)91639-0; Wijdicks EF, Bamlet WR, Maramattom BV, Manno EM, McClelland RL. Validation of a new coma scale: The FOUR score. Ann Neurol. 2005;58(4):585–593. PMID: 16178024 https://doi.org/10.1002/ana.20611Test; Goldstein LB, Bertels C, Davis JN. Interrater reliability of the NIH stroke scale. Arch Neurol. 1989;46(6):660–662. PMID: 2730378 https://doi.org/10.1001/archneur.1989.00520420080026Test; Черпаков Р.А., Гребенчиков О.А. Влияние концентрации хлорида лития на его нейропротекторные свойства при ишемическом инсульте у крыс. Общая реаниматология. 2021;17(5):101–110. https://doi.org/10.15360/1813-9779-2021-5-101-110Test; Gill M, Martens K, Lynch EL, Salih A, Green SM. Interrater reliability of 3 simplified neurologic scales applied to adults presenting to the emergency department with altered levels of consciousness. Ann Emerg Med. 2007;49(4):403–407. PMID: 17141146 https://doi.org/10.1016/j.annemergmed.2006.03.031Test; Fischer M, Rüegg S, Czaplinski A, Strohmeier M, Lehmann A, Tschan F, et al. Inter-rater reliability of the Full Outline of UnResponsiveness score and the Glasgow Coma Scale in critically ill patients: a prospective observational study. Crit Care. 2010;14(2):R64. PMID: 20398274 https://doi.org/10.1186/cc8963Test; Saika A, Bansal S, Philip M, Devi BI, Shukla DP. Prognostic value of FOUR and GCS scores in determining mortality in patients with traumatic brain injury. Acta Neurochir (Wien). 2015;157(8):1323–1328. PMID: 26077394 https://doi.org/10.1007/s00701-015-2469-6Test; Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20(7):864–870. PMID: 2749846 https://doi.org/10.1161/01.str.20.7.864Test; Garavelli F, Ghelfi AM, Kilstein JG. Usefulness of NIHSS score as a predictor of non-neurological in-hospital complications in stroke. Med Clin (Barc). 2021;157(9):434–437. PMID: 33069388 https://doi.org/10.1016/j.medcli.2020.07.034Test; Wu Q, Tang AJ, Zeng L, Niu SZ, Tian MM, Jin AP, et al. Prognosis of Neurological Improvement in Inpatient Acute Ischemic Stroke Survivors: A Propensity Score Matching Analysis. J Stroke Cerebrovasc Dis. 2021;30(1):105437 PMID: 33197800 https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105437Test; Tatebayashi K, Yoshimura S, Sakai N, Uchida K, Kageyama H, Yamagami H, et al. Relationship Between Acute Neurological Function and Long-Term Prognosis in Patients with Large Arterial Occlusions. J Stroke Cerebrovasc Dis. 2021;30(4):105625. PMID: 33497935 https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.105625Test; Wu Z, Zeng M, Li C, Qiu H, Feng H, Xu X, et al. Time-dependence of NIHSS in predicting functional outcome of patients with acute ischemic stroke treated with intravenous thrombolysis. Postgrad Med J. 2019;95(1122):181–186. PMID: 30975729 https://doi.org/10.1136/postgradmedj-2019-136398Test; Abraha HD, Butterworth RJ, Bath PM, Wassif WS, Garthwaite J, Sherwood RA. Serum S-100 protein, relationship to clinical outcome in acute stroke. Ann Clin Biochem. 1997;34( Pt 5):546–550. PMID: 9293311 https://doi.org/10.1177/000456329703400510Test; Fassbender K, Schmidt R, Schreiner A, Fatar M, Mühlhauser F, Daffertshofer M, et al. Leakage of brain-originated proteins in peripheral blood: temporal profile and diagnostic value in early ischemic stroke. J Neurol Sci. 1997;148(1):101–105. PMID: 9125396 https://doi.org/10.1016/s0022-510xTest(96)05351-8; Foerch C, Otto B, Singer OC, Neumann-Haefelin T, Yan B, Berkefeld J, et al. Serum S100B predicts a malignant course of infarction in patients with acute middle cerebral artery occlusion. Stroke. 2004;35(9):2160–2164. PMID: 15297628 https://doi.org/10.1161/01.STR.0000138730.03264.acTest; Lasek-Bal A, Jedrzejowska-Szypulka H, Student S, Warsz-Wianecka A, Zareba K, Puz P, et al. The importance of selected markers of inflammation and blood-brain barrier damage for short-term ischemic stroke prognosis. J Physiol Pharmacol. 2019;70(2). PMID: 31356182 https://doi.org/10.26402/jpp.2019.2.04Test; Foerch C, Wunderlich MT, Dvorak F, Humpich M, Kahles T, Goertler M, et al. Elevated serum S100B levels indicate a higher risk of hemorrhagic transformation after thrombolytic therapy in acute stroke. Stroke. 2007;38(9):2491–2495. PMID: 17673718 https://doi.org/10.1161/STROKEAHA.106.480111Test; Michetti F, D’Ambrosi N, Toesca A, Puglisi MA, Serrano A, Marchese E, et al. The S100B story: from biomarker to active factor in neural injury. J Neurochem. 2019;148(2):168–187. PMID: 30144068 https://doi.org/10.1111/jnc.14574Test; Singh V, Roth S, Veltkamp R, Liesz A. HMGB1 as a Key Mediator of Immune Mechanisms in Ischemic Stroke. Antioxid Redox Signal. 2016;24(12):635–651. PMID: 26493086 https://doi.org/10.1089/ars.2015.6397Test; Elting JW, de Jager AE, Teelken AW, Schaaf MJ, Maurits NM, van der Naalt J, et al. Comparison of serum S-100 protein levels following stroke and traumatic brain injury. J Neurol Sci. 2000;181(1–2):104–110. PMID: 11099719 https://doi.org/10.1016/s0022-510xTest(00)00442-1; Woldegerima N, Rosenblatt K, Mintz CD. Neurotoxic Properties of Propofol Sedation Following Traumatic Brain Injury. Crit Care Med. 2016;44(2):455–456. PMID: 26771796 https://doi.org/10.1097/CCM.00000000000Test; https://www.jnmp.ru/jour/article/view/1513Test

  8. 8
    دورية أكاديمية
  9. 9
    دورية أكاديمية
  10. 10
    دورية أكاديمية